DTCFF
DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC (DTCFF)
$62
About DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC (DTCFF)
Defence Therapeutics, Inc. engages in the research and development of anti-body drug conjugates. It focuses on enhancing intracellular delivery of biological or biosimilar therapeutic drugs targeting cancer and infectious diseases. The company was founded by Simon Beaudoin and Sébastien Plouffe on July 18, 2017 and is headquartered in Vancouver, Canada.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$1.16
52 Week Low
$0.27
Market cap
33.8M
Dividend yield
0.00%
Volume
--
Avg. volume
49
P/E ratio
-9.38
DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$1.16
52 Week Low
$0.27
Market cap
33.8M
Dividend yield
0.00%
Volume
--
Avg. volume
49
P/E ratio
-9.38